Martin Mattingly Net Worth & Insider Trades

Martin Mattingly - Director, Oncogenex Pharmaceuticals, Inc

As of May 27, 2016

What is Martin Mattingly's Net Worth?

The current estimated net worth of Oncogenex Pharmaceuticals, Inc's Director, Martin Mattingly, is estimated to be about $11.32K . Martin Mattingly owns about 1,000 units of Oncogenex Pharmaceuticals, Inc common stock. In the last 6 years at Oncogenex Pharmaceuticals, Inc, Martin Mattingly has sold an estimated value of $0 worth.

What is Martin Mattingly's Past Insider Trading?

Martin Mattingly's largest purchase order was 1,000 units , worth over $12.46K on June 4, 2012. In total, Martin Mattingly has made about 7 transactions over 6 years of their time at Oncogenex Pharmaceuticals, Inc. Martin Mattingly usually trades in May, with the busiest year in 2016.

Martin Mattingly

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Martin Mattingly's' Mailing Address?

  • Mailing address is C/o Trimeris, Inc. 2530 Meridian Parkway, 2nd Floor Durham NC 27713 NC

What are Oncogenex Pharmaceuticals, Inc's Past Insider Trades?

Oncogenex Pharmaceuticals, Inc's most recent insider trade came on August 23, 2016 by John Bencich who sold 1,380 units worth $786.6 . In the last 8 years, insiders at Oncogenex Pharmaceuticals, Inc have sold an estimated value of $8.37M and bought an estimated value of $1.37M worth of shares. Insider trading is most common in May, with the busiest year in 2010. The most active traders at the company are Scott Cormack, President and CEO,  Cindy Jacobs, EVP,  and Neil Clendeninn, Director .

ONCOGENEX PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1